PATENT CLAIM ANALYSIS

Application Number: 15764730
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "004900"]

Abstract:
The disclosure is related to a method of treating a disorder, such as obesity or a condition associated with obesity, such as hyperphagia, in a subject using a melanocortin-4 receptor (MC4R) agonist.

Claim (Index 19):
The method of any of the preceding claims, wherein the agonist is administered subcutaneously, e.g., by subcutaneous injection.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775916', '14800627', '15442229', '13057966', '13074565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8219527357102208
- 35 USC 102 Novelty (BERT): 0.5418818678629227
- Combined Prediction Score: 0.7939456489254909
- Mean Citation Score: 408.489952
- Max Citation Score: 437.57434000000006
- Similarity Product: 213.15785133066657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test